高频超声和前节OCT在外伤性白内障诊治中的应用

注册号:

Registration number:

ChiCTR2600121972 

最近更新日期:

Date of Last Refreshed on:

2026-04-07 17:28:37 

注册时间:

Date of Registration:

2026-04-07 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

高频超声和前节OCT在外伤性白内障诊治中的应用

Public title:

Application of High-Frequency Ultrasound and Anterior Segment OCT in the Diagnosis and Treatment of Traumatic Cataract

注册题目简写:

English Acronym:

研究课题的正式科学名称:

高频超声和前节OCT在外伤性白内障诊治中的应用

Scientific title:

Application of High-Frequency Ultrasound and Anterior Segment OCT in the Diagnosis and Treatment of Traumatic Cataract

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

李想 

研究负责人:

柯屹峰 

Applicant:

li xiang 

Study leader:

Ke yifeng 

申请注册联系人电话:

Applicant telephone:

+86 159 9313 9428

研究负责人电话:

Study leader's
telephone:

+86 22 8642 8838

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

1964689393@qq.com

研究负责人电子邮件:

Study leader's E-mail:

Keyifeng2003@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

天津市西青区西营门街道天百life公寓

研究负责人通讯地址:

高新技术产业开发区华苑产业区榕苑路1号

Applicant address:

Tianbai Life Apartment, Xiyingmen Street, Xiqing District, Tianjin, China

Study leader's address:

high-tech industrial development zone,Huayuan Industrial Zone, No. 1 Rongyuan Road,

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

天津医科大学眼科医院

Applicant's institution:

Tianjin Medical University Eye Hospital

研究负责人所在单位:

天津医科大学眼科医院

Affiliation of the Leader:

Tianjin Medical University Eye Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2026KY-18

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

天津医科大学眼科医院医学伦理委员会

Name of the ethic committee:

Medical Ethics Committee of Tianjin Medical University Eye Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2026-03-11 00:00:00

伦理委员会联系人:

陈卓

Contact Name of the ethic committee:

Chen Zhuo

伦理委员会联系地址:

高新技术产业开发区华苑产业区榕苑路1号

Contact Address of the ethic committee:

high-tech industrial development zone,Huayuan Industrial Zone, No. 1 Rongyuan Road,

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 22 86428817

伦理委员会联系人邮箱:

Contact email of the ethic committee:

1006425222@qq.com

研究实施负责(组长)单位:

天津医科大学眼科医院

Primary sponsor:

Tianjin Medical University Eye Hospital

研究实施负责(组长)单位地址:

高新技术产业开发区华苑产业区榕苑路1号

Primary sponsor's address:

high-tech industrial development zone,Huayuan Industrial Zone, No. 1 Rongyuan Road,

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

天津市

市(区县):

Country:

China

Province:

Tianjin

City:

单位(医院):

天津医科大学眼科医院

具体地址:

高新技术产业开发区华苑产业区榕苑路1号

Institution
hospital:

Tianjin Medical University Eye Hospital

Address:

high-tech industrial development zone,Huayuan Industrial Zone, No. 1 Rongyuan Road,

经费或物资来源:

Source(s) of funding:

None

研究疾病:

外伤性白内障  

Target disease:

Traumatic Cataract

研究疾病代码:

Target disease code:

研究类型:

诊断试验

Study type:

Diagnostic test

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

诊断试验诊断准确性 

Study design:

Diagnostic test for accuracy 

研究目的:

本研究旨在通过高频超声和眼前段OCT评估外伤性白内障患者术前后囊膜完整性,并与术中对比,明确两种检查方法的准确性。  

Objectives of Study:

This study aims to evaluate the integrity of the posterior capsule in patients with traumatic cataract using high-frequency ultrasound and anterior segment OCT, compare the findings with intraoperative observations, and determine the accuracy of the two examination methods.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1.严重眼外伤;
2.损伤累及视网膜黄斑区功能;
3.角膜损伤引起巨大瘢痕及严重散光;
4.眼部有手术史;

Exclusion criteria:

1.severe ocular trauma;
2.involving macular function;
3.massive corneal scarring and severe astigmatism caused by corneal injury;
4.history of ocular surgery;

研究实施时间:

Study execute time:

From 2026-04-06 00:00:00 To 2027-02-24 00:00:00  

征募观察对象时间:

Recruiting time:

From 2026-04-07 00:00:00 To 2027-02-24 00:00:00

诊断试验:

Diagnostic Tests:

金标准或参考标准(即可准确诊断某疾病的单项方法或多项联合方法,在本研究中用于诊断是否有该病的临床参考标准):

术中观察到的后囊膜状况外伤性白内障

Gold Standard or Reference Standard (The clinical reference standards required to establish the presence or absence of the target condition in the tested population in present study):

The intraoperative observation of posterior capsule status in patients with traumatic cataract.

指标试验(即本研究的待评估诊断试验,无论为方法、生物标志物或设备,均请列出名称):

眼前节光学相干断层扫描(TOMEY CASIA2);mindray多谱勒超声仪,超声探头20 MHz。

Index test:

Anterior segment optical coherence tomography (TOMEY CASIA2); Mindray Doppler ultrasound system with a 20 MHz ultrasound probe.

目标人群(可以是某种疾病患者或正常人群,详细描述其疾病特征,注意应纳入符合分布特点的全序列病例,具有良好的代表性)

患有外伤性白内障的患者

例数:

Sample size:

50

Target condition (The target condition is a particular disease or disease stage that the index test will be intended to identify. Please specify the characteristics in detail; the population should has a complete spectrum and good representative):

Patients with traumatic cataract

容易混淆的疾病人群(即与目标疾病不易区分的一种或多种不同疾病,应避免采用正常人群对照的病例-对照设计):

例数:

Sample size:

0

Population with condition difficult to distinguish from the target condition, the normal population in a case-control study design should be avoid:

None

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

天津市 

市(区县):

 

Country:

China

Province:

Tianjin

City:

单位(医院):

天津医科大学眼科医院 

单位级别:

三级甲等 

Institution
hospital:

Tianjin Medical University Eye Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

后囊膜完整性评估结果

指标类型:

主要指标

Outcome:

Posterior capsule integrity assessment

Type:

Primary indicator

测量时间点:

术前(高频超声及眼前段OCT检查时);术中(作为金标准对照)

测量方法:

高频超声(20 MHz)观察后囊膜连续性、有无缺损;眼前段OCT(TOMEY CASIA2)观察后囊膜形态及完整性;术中显微镜下直接观察并记录后囊膜状态

Measure time point of outcome:

Preoperative (during high-frequency ultrasound and anterior segment OCT examination); Intraoperative

Measure method:

High-frequency ultrasound (20 MHz) to assess posterior capsule continuity and defects; anterior segment OCT (TOMEY CASIA2) to evaluate posterior capsule morphology and integrity; intraoperative direct observation under microscope to record posterior capsule status

指标中文名:

准确度

指标类型:

主要指标

Outcome:

Accuracy

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

特异性

指标类型:

主要指标

Outcome:

specificity

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

NA

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 20 years
最大 Max age 70 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

None

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

不共享

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Not shared

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form

数据与安全监察委员会:

Data and Safety Monitoring Committee:

无/No

注册人:

Name of Registration:

 2026-04-07 17:28:15